VERTEX PHARMACEUTICALS INC / MA: net_income
| Value | {"amount": 1176800000, "concept": "us-gaap:NetIncomeLoss", "currency": "USD"} |
|---|---|
| Period | 2019-01-01 – 2019-12-31 |
| Status | current |
| Entity | VERTEX PHARMACEUTICALS INC / MA |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T08:42:23.584083+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/f7e1f6c9-b522-4df1-a2d1-db6a1e17b10d
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0000875320-22-000007Retrieved: 2026-08-19T08:42:23.584083+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0000875320/net-income/2019-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/f7e1f6c9-b522-4df1-a2d1-db6a1e17b10d
History
- supersedes {"amount": 1176810000, "concept": "us-gaap:NetIncomeLoss", "currency": "USD"} (evidence 0000875320-20-000007)